Overview
CT/NG NAATs detect C. trachomatis and N. gonorrhoeae DNA/RNA from urogenital, extragenital, or other validated specimen types.
Clinical Importance
Screen and diagnose chlamydia and gonorrhea
Test extragenital sites in at-risk patients when validated
Specimen Requirements
- Specimen: first-catch urine, vaginal/endocervical/urethral swabs, or validated extragenital swabs
- Device: assay-specific collection kits
- Handling: observe transport stability; do not use wooden shafts/swabs contraindicated by IFU
Analytical Method
Target amplification detects CT and NG nucleic acids, often in duplex assays. Gonorrhea NAAT-positive results may require culture for AST in treatment-failure or resistance-surveillance pathways.
Instruments Used
Automated analyzers
- Hologic Aptima Combo assays on Panther
- Roche Cobas CT/NG systems
- Other validated STI NAAT platforms
Manual methods
- Laboratory-developed duplex PCR in specialized settings
Reference Values
Molecular cutoffs, units (IU/mL, copies/mL, Ct), reportable ranges, and variant classifications are assay- and laboratory-specific. Always interpret against the performing laboratory report, manufacturer IFU, and current CLSI / CAP / AMP / ACMG guidance as adopted locally. Limit of detection and inhibition controls are essential for negative results.
Not detected expected without infection. Detected = nucleic acid present; clinical correlation for site.
Interpretation
Common Causes of Increased Results
- CT and/or NG detected; treat per STI guidelines; consider partner management
Common Causes of Decreased Results
- Not detected; does not exclude all STI pathogens
Clinical Significance
- STI screening and diagnosis
Factors Affecting Results
Pre-analytical
- Wrong specimen type or transport medium for the validated assay
- Delayed transport degrading RNA targets
- Contamination during collection (especially amplicon-rich environments)
- Inadequate volume or low cellularity/tumor content
Analytical
- PCR inhibition (heparin, humic acids, excess hemoglobin; assay-dependent)
- Extraction failure or pipetting/contamination in amplification areas
- Probe/primer mismatch with sequence variants causing false negatives
- Calibration/QC failure; expired reagents
Post-analytical
- Reporting Ct or raw copies without assay-specific interpretive rules
- Misapplying another laboratory’s LOD or units
- Variant classification without current ACMG/AMP framework when required
Advantages and Limitations
Advantages
- Higher sensitivity than culture for CT
- High throughput screening
Limitations
- NG AST still needs culture isolates
- Extragenital validation assay-specific
Clinical Pearls
NAAT finds gonorrhea fast; culture still owns the susceptibility answer when resistance matters.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Elsevier; 2021. (Molecular diagnostics chapters, verify current edition.)
- Buckingham L. Molecular Diagnostics: Fundamentals, Methods, and Clinical Applications. 3rd ed. F.A. Davis; 2019. (Verify current edition and institutional adoption.)
CLSI and Professional Guidelines
- Clinical and Laboratory Standards Institute (CLSI). Consult current CLSI molecular method documents available through your laboratory, document numbers and editions change; do not treat any single CLSI title as universal.
- Institutional molecular laboratory standard operating procedures (SOPs), assay manufacturer instructions for use (IFU), and locally adopted accreditation requirements. Always verify current local practice.
- Clinical and Laboratory Standards Institute (CLSI). Molecular method evaluation and related documents (verify current CLSI editions applicable to the assay).
- College of American Pathologists. Molecular pathology accreditation and proficiency testing expectations (verify current CAP checklist requirements).
- Association for Molecular Pathology (AMP). Practice guidelines and position statements for molecular diagnostics (verify current AMP documents for the assay).
- American College of Medical Genetics and Genomics (ACMG). Standards and guidelines for interpretation of sequence variants and related genetic testing practice (verify current ACMG documents).
WHO Publications
- World Health Organization. Laboratory and diagnostic guidance relevant to molecular testing (verify current WHO publication for the assay/pathogen).
Frequently Asked Questions
Common questions about using this CT/NG NAAT laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the CT/NG NAAT laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of CT/NG NAAT. Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find CT/NG NAAT specimen requirements?
See the Specimen Requirements section on this page for specimen information related to CT/NG NAAT. Confirm collection details against your laboratory protocol.
Where are CT/NG NAAT reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret CT/NG NAAT results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for CT/NG NAAT?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from CT/NG NAAT?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading CT/NG NAAT?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Molecular Diagnostics topic.
What are the clinical pearls for CT/NG NAAT?
See the Clinical Pearls section for concise laboratory practice notes associated with CT/NG NAAT. Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.